Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Thomassin, Jenny Lee ^a   Lee, Mark J ^a   Brannon, John R ^a   Sheppard, Donald C ^a   Gruenheid, Samantha ^a   Le Moual, Hervé ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 5; O ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CAPSULE; BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CONTROLLED STUDY; DELETION MUTANT; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; GFCA GENE; HOST PATHOGEN INTERACTION; NONHUMAN;

ALPHA-DEFENSINS; ANTI-INFECTIVE AGENTS; BACTERIAL CAPSULES; DRUG RESISTANCE, BACTERIAL; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; O ANTIGENS; POLYSACCHARIDES, BACTERIAL; SEQUENCE DELETION;

EID: 84891790412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082475     Document Type: Article

References (55)

1. Clarke SC, Haigh RD, Freestone PP, Williams PH (2002) Enteropathogenic Escherichia coli infection: history and clinical aspects. Br J Biomed Sci 59: 123-127. PubMed: 12113403.
2. Donnenberg MS, Finlay BB (2013) Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward. Trends Microbiol 21: 317-319. doi:10.1016/j.tim.2013.05.003. PubMed: 23815982.
3. Nataro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201. PubMed: 9457432.
4. Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086. doi:10.1016/S0140-6736(05)74232-X. PubMed: 15781103.
5. Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB et al. (1998) Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol 30: 911-921. doi:10.1046/j.1365-2958.1998.01144.x. PubMed: 9988469.
6. Croxen MA, Finlay BB (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8: 26-38. PubMed: 19966814.
7. Law RJ, Gur-Arie L, Rosenshine I, Finlay BB (2013) In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med 3: a009977. PubMed: 23457294.
8. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395. doi:10.1038/415389a. PubMed: 11807545.
9. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557. doi:10.1038/nbt1267. PubMed: 17160061.
10. Lehrer RI, Lu W (2012) Alpha-defensins in human innate immunity. Immunol Rev 245: 84-112. doi:10.1111/j.1600-065X.2011.01082.x. PubMed: 22168415.
11. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250. doi:10.1038/nrmicro1098. PubMed: 15703760.
12. Gruenheid S, Le Moual H (2012) Resistance to antimicrobial peptides in Gram-negative bacteria. FEMS Microbiol Lett 330: 81-89. doi: 10.1111/j.1574-6968.2012.02528.x. PubMed: 22339775.
13. Roberts IS (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol 50: 285-315. doi:10.1146/annurev.micro.50.1.285. PubMed: 8905082.
14. Whitfield C (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75: 39-68. doi: 10.1146/annurev.biochem. 75.103004.142545. PubMed: 16756484.
15. Llobet E, Tomás JM, Bengoechea JA (2008) Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154: 3877-3886. doi:10.1099/mic.0.2008/022301-0. PubMed: 19047754.
16. Nagy G, Danino V, Dobrindt U, Pallen M, Chaudhuri R et al. (2006) Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate. Infect Immun 74: 5914-5925. doi:10.1128/IAI.00619-06. PubMed: 16988271.
17. Banemann A, Deppisch H, Gross R (1998) The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect Immun 66: 5607-5612. PubMed: 9826332.
18. Campos MA, Vargas MA, Regueiro V, Llompart CM, Albertí S et al. (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72: 7107-7114. doi:10.1128/IAI. 72.12.7107-7114.2004. PubMed: 15557634.
19. Peleg A, Shifrin Y, Ilan O, Nadler-Yona C, Nov S, et al. (2005) Identification of an Escherichia coli operon required for formation of the O-antigen capsule. J Bacteriol 187: 5259-5266.
20. Widmalm G, Leontein K (1993) Structural studies of the Escherichia coli O127 O-antigen polysaccharide. Carbohydr Res 247: 255-262. doi: 10.1016/0008-6215(93)84258-8. PubMed: 7693348.
21. Stenutz R, Weintraub A, Widmalm G (2006) The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev 30: 382-403. doi:10.1111/j.1574-6976.2006.00016.x. PubMed: 16594963.
22. Wang L, Reeves PR (1998) Organization of Escherichia coli O157 O-antigen gene cluster and identification of its specific genes. Infect Immun 66: 3545-3551. PubMed: 9673232.
23. Perry MB, MacLean L, Griffith DW (1986) Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli O157:H7. Biochem Cell Biol 64: 21-28. doi:10.1139/o86-004. PubMed: 3008786.
24. Sathiyamoorthy K, Mills E, Franzmann TM, Rosenshine I, Saper MA (2011) The crystal structure of Escherichia coli group 4 capsule protein GfcC reveals a domain organization resembling that of Wza. Biochemistry 50: 5465-5476. doi:10.1021/bi101869h. PubMed: 21449614.
25. Shifrin Y, Peleg A, Ilan O, Nadler C, Kobi S et al. (2008) Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule. J Bacteriol 190: 5063-5074. doi:10.1128/JB.00440-08. PubMed: 18502854.
26. Bevins CL, Salzman NH (2011) Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9: 356-368. doi:10.1038/nrmicro2546. PubMed: 21423246.
27. Clevers HC, Bevins CL (2013) Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol 75: 289-311. doi:10.1146/annurev-physiol- 030212-183744. PubMed: 23398152.
28. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526. doi:10.1038/nature01520. PubMed: 12660734.
29. Chu H, Pazgier M, Jung G, Nuccio SP, Castillo PA et al. (2012) Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 337: 477-481. doi:10.1126/science.1218831. PubMed: 22722251.
30. Ericksen B, Wu Z, Lu W, Lehrer RI (2005) Antibacterial activity and specificity of the six human alpha-defensins. Antimicrob Agents Chemother 49: 269-275. doi:10.1128/AAC.49.1.269-275.2005. PubMed: 15616305.
31. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjöberg J et al. (2010) Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11: 76-83. doi:10.1038/ni.1825. PubMed: 19855381.
32. Shirin T, Rahman A, Danielsson A, Uddin T, Bhuyian TR et al. (2011) Antimicrobial peptides in the duodenum at the acute and convalescent stages in patients with diarrhea due to Vibrio cholerae O1 or enterotoxigenic Escherichia coli infection. Microbes Infect 13: 1111-1120. doi:10.1016/j.micinf.2011.06.014. PubMed: 21782033.
33. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF (2002) Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 70: 953-963. doi:10.1128/IAI.70.2.953-963.2002. PubMed: 11796631.
34. Thomassin JL, Brannon JR, Gibbs BF, Gruenheid S, Le Moual H (2012) OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37. Infect Immun 80: 483-492. doi:10.1128/IAI.05674-11. PubMed: 22144482.
35. Thomassin JL, Brannon JR, Kaiser J, Gruenheid S, Le Moual H (2012) Enterohemorrhagic and enteropathogenic Escherichia coli evolved different strategies to resist antimicrobial peptides. Gut Microbes 3: 556-561. doi:10.4161/gmic.21656. PubMed: 22895086.
36. Ferrières L, Aslam SN, Cooper RM, Clarke DJ (2007) The yjbEFGH locus in Escherichia coli K-12 is an operon encoding proteins involved in exopolysaccharide production. Microbiology 153: 1070-1080. doi: 10.1099/mic.0.2006/002907-0. PubMed: 17379715.
37. Håkansson S, Holm SE, Wagner M (1987) Density profile of group B streptococci, type III, and its possible relation to enhanced virulence. J Clin Microbiol 25: 714-718. PubMed: 3106411.
38. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME et al. (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1: 113-118. doi:10.1038/77783. PubMed: 11248802.
39. Ghosh D, Porter E, Shen B, Lee SK, Wilk D et al. (2002) Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 3: 583-590. doi:10.1038/ni797. PubMed: 12021776.
40. Zilbauer M, Jenke A, Wenzel G, Goedde D, Postberg J et al. (2011) Intestinal alpha-defensin expression in pediatric inflammatory bowel disease. Inflamm Bowel Dis 17: 2076-2086. doi:10.1002/ibd.21577. PubMed: 21910169.
41. Maemoto A, Qu X, Rosengren KJ, Tanabe H, Henschen-Edman A et al. (2004) Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J Biol Chem 279: 44188-44196. doi:10.1074/jbc.M406154200. PubMed: 15297466.
42. Lehrer RI, Jung G, Ruchala P, Andre S, Gabius HJ et al. (2009) Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol 183: 480-490. doi:10.4049/jimmunol.0900244. PubMed: 19542459.
43. Goldman RC, White D, Orskov F, Orskov I, Rick PD et al. (1982) A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol 151: 1210-1221. PubMed: 6179923.
44. Patrick S, Houston S, Thacker Z, Blakely GW (2009) Mutational analysis of genes implicated in LPS and capsular polysaccharide biosynthesis in the opportunistic pathogen Bacteroides fragilis. Microbiology 155: 1039-1049. doi:10.1099/mic.0.025361-0. PubMed: 19332806.
45. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual; CS Harbor. NY: Cold Spring Harbor Laboratory Press.
46. Donnenberg MS, Kaper JB (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 59: 4310-4317. PubMed: 1937792.
47. -ΔΔCT method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609.
48. + Klebsiella pneumoniae-induced lethal disease by evading Toll-like receptor 4 signaling. Infect Immun 77: 615-621. doi:10.1128/IAI.00931-08. PubMed: 19015249.
49. Mount KL, Townsend CA, Bauer ME (2007) Haemophilus ducreyi is resistant to human antimicrobial peptides. Antimicrob Agents Chemother 51: 3391-3393. doi:10.1128/AAC.00473-07. PubMed: 17620373.
50. Tsai CM, Frasch CE (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115-119. doi:10.1016/0003-2697(82)90673-X. PubMed: 6176137.
51. Dubois M, Gilles K, Hamilton J, Rebers P, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28: 350-356. doi:10.1021/ac60111a017.
52. Johnson AR (1971) Improved method of hexosamine determination. Anal Biochem 44: 628-635. doi:10.1016/0003-2697(71)90252-1. PubMed: 5130949.
53. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG et al. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681-685. doi:10.1056/NEJM198303243081203. PubMed: 6338386.
54. Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB et al. (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 1: 1119-1122. PubMed: 77415.
55. Edwards RA, Keller LH, Schifferli DM (1998) Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207: 149-157. doi:10.1016/S0378-1119(97)00619-7. PubMed: 9511756.